Shi X, Feng D, Wei W
Front Surg. 2021; 8:753547.
PMID: 34869561
PMC: 8634134.
DOI: 10.3389/fsurg.2021.753547.
Tomaszewski J, Smaldone M
Open Access J Urol. 2013; 2:67-84.
PMID: 24198616
PMC: 3818881.
Jeong C, Jeon H, Kwak C, Jeong H, Lee S
Cancer Res Treat. 2009; 37(1):44-7.
PMID: 19956509
PMC: 2785421.
DOI: 10.4143/crt.2005.37.1.44.
Sylvester R, Oosterlinck W, Witjes J
Eur Urol. 2008; 53(4):709-19.
PMID: 18207317
PMC: 2587437.
DOI: 10.1016/j.eururo.2008.01.015.
Witjes J
Drugs. 1997; 53(3):404-14.
PMID: 9074842
DOI: 10.2165/00003495-199753030-00005.
Treatment of experimental mouse bladder tumour by LPS-induced epithelial cell shedding.
Nativ O, Medalia O, Mor Y, Shajrawi I, Sabo E, Aronson M
Br J Cancer. 1996; 74(4):603-5.
PMID: 8761377
PMC: 2074659.
DOI: 10.1038/bjc.1996.408.
Chemotherapy for bladder cancer in the elderly.
Raghavan D
Drugs Aging. 1993; 3(1):1-8.
PMID: 8453182
DOI: 10.2165/00002512-199303010-00001.
The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guérin for prophylaxis of recurrence of superficial bladder cancer: a preliminary report.
Uekado Y, Hirano A, Shinka T, Ohkawa T
Cancer Chemother Pharmacol. 1994; 35 Suppl:S65-8.
PMID: 7994790
DOI: 10.1007/BF00686923.
A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer. The Nagoya University Urological Oncology Group.
Okamura K, Murase T, Obata K, Ohshima S, Ono Y, Sakata T
Cancer Chemother Pharmacol. 1994; 35 Suppl:S31-5.
PMID: 7994783
DOI: 10.1007/BF00686916.
Superficial bladder cancer: state of the art.
Bono A
Cancer Chemother Pharmacol. 1994; 35 Suppl:S101-9.
PMID: 7994780
DOI: 10.1007/BF00686931.
Bladder instillation of adriamycin in the treatment of bladder cancer.
Huang C, Chiang C
Cancer Chemother Pharmacol. 1983; 11 Suppl:S91-3.
PMID: 6605814
DOI: 10.1007/BF00256728.
Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer.
Niijima T, Koiso K, Akaza H
Cancer Chemother Pharmacol. 1983; 11 Suppl:S79-82.
PMID: 6416701
DOI: 10.1007/BF00256725.
Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project.
FRIEDELL G
Cancer Chemother Pharmacol. 1983; 11 Suppl:S13-5.
PMID: 6416697
Intravesical chemotherapy in the United States. An overview.
Spaulding J
Cancer Chemother Pharmacol. 1983; 11 Suppl:S5-8.
PMID: 6196136
DOI: 10.1007/BF00256708.
Preoperative doxorubicin instillation in recurrent superficial bladder cancer.
Kubota Y, Noguchi S, Shuin T, Moriyama M, Hosaka M, Satomi Y
Cancer Chemother Pharmacol. 1987; 20 Suppl:S56-9.
PMID: 3664944
DOI: 10.1007/BF00262487.
Invasive bladder cancer--possible future treatment considerations.
Gardiner R
Urol Res. 1986; 14(4):191-4.
PMID: 3538608
DOI: 10.1007/BF00441112.
Prophylactic treatment for superficial bladder cancer following transurethral resection.
Hirao Y, Okajima E, OHara S, Ozono S, Hiramatsu T, Yoshida K
Cancer Chemother Pharmacol. 1987; 20 Suppl:S85-90.
PMID: 3117402
DOI: 10.1007/BF00262494.
Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C.
ISAKA S, Okano T, Shimazaki J, Igarashi T, Murakami S, Higa T
Cancer Chemother Pharmacol. 1987; 20 Suppl:S77-80.
PMID: 3117401
DOI: 10.1007/BF00262492.
Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer.
Tsushima T, Matsumura Y, Ozaki Y, Yoshimoto J, Ohmori H
Cancer Chemother Pharmacol. 1987; 20 Suppl:S72-6.
PMID: 3117400
DOI: 10.1007/BF00262491.
Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors.
Fukui I, Sekine H, Kihara K, Yamada T, Kawai T, Washizuka M
Cancer Chemother Pharmacol. 1987; 20 Suppl:S52-5.
PMID: 3117399
DOI: 10.1007/BF00262486.
